Gilead Sciences Inc (NAS:GILD)
$ 67.86 0.865 (1.29%) Market Cap: 84.54 Bil Enterprise Value: 105.02 Bil PE Ratio: 188.50 PB Ratio: 4.82 GF Score: 77/100

Q2 2020 Gilead Sciences Inc Earnings Call Transcript

Jul 30, 2020 / 08:30PM GMT
Release Date Price: $72.33 (-0.93%)
Operator

Ladies and gentlemen, thank you for standing by and welcome to the Second Quarter 2020 Gilead Sciences Earnings Conference Call. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions)

I'd now like to hand the conference over to your host today, Mr. Douglas Maffei, Senior Director of Investor Relations. Please go ahead.

Douglas Maffei
Gilead Sciences, Inc. - Senior Director of IR

Thank you, Liz, and good afternoon, everyone. Just after market closed today, we issued a press release with earnings results for the first half and second quarter of 2020. The press release and detailed slides are available on the Investors section of the Gilead website.

The speakers on today's call will be Daniel O'Day, Chairman and Chief Executive Officer; Johanna Mercier, Chief Commercial Officer; Merdad Parsey, Chief Medical Officer; and Andrew Dickinson, Chief Financial Officer. Also on the call and available for Q&A will be Christi Shaw, Chief Executive Officer of Kite; and Diana Brainard, SVP and Head of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot